Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Therapeutics
400+
Companies
More info
Parent markets
Medical
Health Care
Sibling markets
Health and Insurance
Medical Devices
Pharmaceuticals
Medical Professionals
Hospitals
Clinical Trials
Diagnostics
Related markets
Networking
Video
Software
400+ companies in Therapeutics
Show all
Amgen Inc.
Manufacturing +2
Seattle Genetics
Health Care +2
Ophelia
Health Care +2
Takeda
Pharmaceuticals +1
Deep Genomics
Artificial Intelligence +2
Aimmune
Health and Wellness +2
Kaia Health
Artificial Intelligence +2
Beam Therapeutics
Health Care +1
Cerevel Therapeutics
Biotechnology +1
Pear Therapeutics
Biotechnology +1
Xealth
Personal Health +3
SilverCloud Health
Enterprise Software +2
Moderna Therapeutics
Biotechnology +1
Neuronetics, Inc.
Biotechnology +2
Aspen Neuroscience
Medical +2
All companies in Therapeutics
News
Funding rounds
Acquisitions
Companies
Investors
Filter companies
11 Nov
2021
Nuritas
$45,000,000
Venture capital (Series B)
Cultivian Sandbox Ventures
,
Wheatsheaf Group
,
Cleveland Avenue
,
+6
BREAKING: Nuritas raises $45 million to scale its plant-based peptides discovery platform
AFN
+1
03 Nov
2021
GRO Biosciences
$25,000,000
Venture capital (Series A)
Redmile Group
,
Innovation Endeavors
,
Digitalis Ventures
,
+1
Synbio startup GRObio gets $25M to work with new building blocks for protein drugs
MedCity News
27 Oct
2021
Immunai
$215,000,000
Venture capital (Series B)
Icon Ventures
,
Piedmont Capital
,
8VC
,
+3
Immunai announces a $215M Series B as its ‘immune cell atlas’ matures
TechCrunch
25 Oct
2021
Click Therapeutics
$52,000,000
Venture capital (Series B)
Accelmed
,
H.I.G. BioHealth Partners
,
Health Catalyst Capital
,
+5
Click Therapeutics raises $52M, looks to advance digital therapeutics
MedCity News
22 Oct
2021
Egle Therapeutics
€40,000,000
Venture capital (Series A)
Bpifrance
,
Life Sciences Partners
,
Fund+
,
+2
Already allied with Takeda, Egle raises €40M for its ‘starving’ immunotherapy
MedCity News
27 Sep
2021
Delix Therapeutics
$70,000,000
Venture capital (Series A)
RA Capital Management
,
Dolby Family Ventures
,
ARTIS Ventures
,
+15
Psychedelic drugs, but safer: Delix raises $70M to bring new neuro meds to clinic
MedCity News
23 Sep
2021
GenEdit Inc
$26,000,000
Venture capital (Series A)
Sequoia Capital
,
IMM Investment
,
Korea Investment Partners
,
+7
Aiming for better genetic medicines delivery, startup GenEdit grabs $26M
MedCity News
13 Sep
2021
Walking Fish Therapeutics
$50,000,000
Venture capital (Series A)
Emerson Collective
,
Illumina Ventures
,
Quan Capital
Startup Walking Fish nabs $50M to run with B cell therapies for cancer & more
MedCity News
09 Sep
2021
Neuroglee Therapeutics
$10,000,000
Venture capital (Series A)
EDBI
,
Openspace Ventures
,
Ramen Singh
,
+3
Digital therapeutics startup Neuroglee raises $10M to help people with neurodegenerative conditions
TechCrunch
09 Sep
2021
DotCom Therapy
$8,800,000
Venture capital (Series A)
New Capital Partners
,
OSF Ventures
,
LRVHealth
DotCom Therapy raises $13M to provide therapy for kids, in and out of school
TechCrunch
01 Sep
2021
Asher Bio
$108,000,000
Venture capital (Series B)
RA Capital Management
,
Invus
,
Third Rock Ventures
,
+7
Asher Bio’s encouraging early data against rival cancer drug sparks $108M financing
MedCity News
31 Aug
2021
Alma
$50,000,000
Venture capital (Series C)
Insight Partners
Alma gets $50M to boost therapists’ practices
MedCity News